Investigations into berberine and depression have been compelling, with preliminary results suggesting that berberine supplements may serve as an impressively effective antidepressant.
A growing body of literature suggests that CBD is a well-tolerated adjunct therapy that will aid recovery and make patients more comfortable during and after chemotherapy.
Evidence suggests that butyric acid supplementation can provide the critical support needed to improve the health of the gut microbiome and help patients optimize well-being.
Many nutritional supplements have historically suffered from poor bioavailability, but new technologies are paving the way for improved therapeutic efficacy and giving patients a fresh chance to heal.
For those who are interested in integrating cannabinoids in their treatment plans, understanding these differences between CBD and THC is essential to optimize therapeutic benefits while minimizing risk.
In part two of our interview, Walter Crinnion expands his discussion on the most pernicious environmental toxins and shares practical strategies for mitigating their impact.
In the first of a two-part interview, Walter Crinnion shares his thoughts on the most pressing environmental hazards of our time and how members of the public can protect themselves from common toxins.
For patients and practitioners who are looking beyond conventional treatment to address the neurocognitive effects of dementia, quercetin, butyrate, and glutathione may offer significant benefits.
As the dangers of oxidative stress become increasingly evident, there is reason to believe that lowering this stress via glutathione supplementation could help patients optimize well-being.
Though GABA’s impact in the body is well-understood, far less is known about the efficacy or side effects of GABA supplements, and patients may wish to investigate alternative supplementation for greater therapeutic potential and known safety.